Cargando…
Antimicrobial-associated harm in critical care: a narrative review
The belief that, for the individual patient, the benefit of prompt and continued use of antimicrobials outweighs any potential harm is a significant barrier to improved stewardship of these vital agents. Antimicrobial stewardship may be perceived as utilitarian rationing, seeking to preserve the ava...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046486/ https://www.ncbi.nlm.nih.gov/pubmed/31996961 http://dx.doi.org/10.1007/s00134-020-05929-3 |
_version_ | 1783501955411214336 |
---|---|
author | Arulkumaran, Nishkantha Routledge, Matthew Schlebusch, Sanmarié Lipman, Jeffrey Conway Morris, Andrew |
author_facet | Arulkumaran, Nishkantha Routledge, Matthew Schlebusch, Sanmarié Lipman, Jeffrey Conway Morris, Andrew |
author_sort | Arulkumaran, Nishkantha |
collection | PubMed |
description | The belief that, for the individual patient, the benefit of prompt and continued use of antimicrobials outweighs any potential harm is a significant barrier to improved stewardship of these vital agents. Antimicrobial stewardship may be perceived as utilitarian rationing, seeking to preserve the availability of effective antimicrobials by limiting the development of resistance in a manner which could conflict with the immediate treatment of the patient in need. This view does not account for the growing evidence of antimicrobial-associated harm to individual patients. This review sets out the evidence for antimicrobial-associated harm and how this should be balanced with the need for prompt and appropriate therapy in infection. It describes the mechanisms by which antimicrobials may harm patients including: mitochondrial toxicity; immune cell toxicity; adverse drug reactions; selection of resistant organisms within a given patient; and disruption of the microbiome. Finally, the article indicates how the harms of antimicrobials may be mitigated and identifies areas for research and development in this field. |
format | Online Article Text |
id | pubmed-7046486 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-70464862020-05-15 Antimicrobial-associated harm in critical care: a narrative review Arulkumaran, Nishkantha Routledge, Matthew Schlebusch, Sanmarié Lipman, Jeffrey Conway Morris, Andrew Intensive Care Med Narrative Review The belief that, for the individual patient, the benefit of prompt and continued use of antimicrobials outweighs any potential harm is a significant barrier to improved stewardship of these vital agents. Antimicrobial stewardship may be perceived as utilitarian rationing, seeking to preserve the availability of effective antimicrobials by limiting the development of resistance in a manner which could conflict with the immediate treatment of the patient in need. This view does not account for the growing evidence of antimicrobial-associated harm to individual patients. This review sets out the evidence for antimicrobial-associated harm and how this should be balanced with the need for prompt and appropriate therapy in infection. It describes the mechanisms by which antimicrobials may harm patients including: mitochondrial toxicity; immune cell toxicity; adverse drug reactions; selection of resistant organisms within a given patient; and disruption of the microbiome. Finally, the article indicates how the harms of antimicrobials may be mitigated and identifies areas for research and development in this field. Springer Berlin Heidelberg 2020-01-29 2020 /pmc/articles/PMC7046486/ /pubmed/31996961 http://dx.doi.org/10.1007/s00134-020-05929-3 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Narrative Review Arulkumaran, Nishkantha Routledge, Matthew Schlebusch, Sanmarié Lipman, Jeffrey Conway Morris, Andrew Antimicrobial-associated harm in critical care: a narrative review |
title | Antimicrobial-associated harm in critical care: a narrative review |
title_full | Antimicrobial-associated harm in critical care: a narrative review |
title_fullStr | Antimicrobial-associated harm in critical care: a narrative review |
title_full_unstemmed | Antimicrobial-associated harm in critical care: a narrative review |
title_short | Antimicrobial-associated harm in critical care: a narrative review |
title_sort | antimicrobial-associated harm in critical care: a narrative review |
topic | Narrative Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046486/ https://www.ncbi.nlm.nih.gov/pubmed/31996961 http://dx.doi.org/10.1007/s00134-020-05929-3 |
work_keys_str_mv | AT arulkumarannishkantha antimicrobialassociatedharmincriticalcareanarrativereview AT routledgematthew antimicrobialassociatedharmincriticalcareanarrativereview AT schlebuschsanmarie antimicrobialassociatedharmincriticalcareanarrativereview AT lipmanjeffrey antimicrobialassociatedharmincriticalcareanarrativereview AT conwaymorrisandrew antimicrobialassociatedharmincriticalcareanarrativereview |